Is This Healthcare Stock Set To Rally?
Eli Lilly has been a frustrating hold so far this year. Shares are slightly down year to date, a rare stumble for a company that has delivered nearly 5x returns over the past five years.
For a stock that’s become a poster child of the weight-loss and diabetes boom, the slowdown in momentum has left investors wondering if the story has run its course.
» Read more about: Is This Healthcare Stock Set To Rally? »
Read More
4% Dividend + 12x Earnings = Blockbuster in the Making
Merck has long been a pillar of stability in the pharmaceutical world, thanks in large part to the staggering success of its cancer drug Keytruda. But behind that success lies a quietly growing concern of what happens when the patents expire?
In a move that could reshape its future, Merck just announced a $10 billion acquisition of Verona Pharma.
» Read more about: 4% Dividend + 12x Earnings = Blockbuster in the Making »
Read More
Could BigBear.ai Stock Really 3x?
BigBear.ai (NYSE: BBAI) has all the buzzwords that investors love these days AI, defense, government contracts but does that make it a great investment?
Some traders are hoping the stock will 3x but as any seasoned investor knows, hope isn’t a strategy. If you’re wondering what it would actually take to get there,
» Read more about: Could BigBear.ai Stock Really 3x? »
Read More
Why Lyft Might Be The Highest Potential Stock Now
In the world of rideshare investing, Uber tends to get all the attention. And with autonomous driving hype swirling around Tesla, it’s easy to overlook the other major U.S. player in the space. But if you’re willing to dig deeper, Lyft (NASDAQ: LYFT) might just be one of the market’s most overlooked opportunities.
Key Points
-
Lyft targets the $59.2B U.S.
» Read more about: Why Lyft Might Be The Highest Potential Stock Now »
Read More
Is AppLovin Still a Buy After Its Incredible Run?
AppLovin (NASDAQ: APP) has had the kind of year investors dream about. The mobile app marketing and advertising platform, best known for its strength in mobile gaming has seen its stock rocket more than 5x over the past 12 months, fueled by relentless revenue growth and eye-popping profits.
With a move that big,
» Read more about: Is AppLovin Still a Buy After Its Incredible Run? »
Read MoreThe Burst
The AI Gold Rush Has an Overlooked Winner
Chipmakers, cloud giants, and software platforms are all basking in the AI spotlight. But there’s a truth hiding beneath the frenzy, which is that none of this technology can function without massive amounts of electricity. And that’s where Dominion Energy steps in.
Key Points
-
AI will triple U.S.
» Read more about: The AI Gold Rush Has an Overlooked Winner »
Read MoreThe Spotlight
Is This 8.6% Yield Too Good to Ignore?
If you’re the kind of investor who wants steady income, especially the kind that drops into your account every month like clockwork, the JPMorgan Equity Premium Income ETF (JEPI) is tough to ignore.
The headline number is eye-catching, an 8.6% trailing yield, paid monthly. That’s not just high, it’s more than four times the yield of the S&P 500 and well above what most high-grade corporate bonds are paying right now.
» Read more about: Is This 8.6% Yield Too Good to Ignore? »
Read MoreThe Daily
3 Genius Ways to Invest in Quantum Computing and Artificial Intelligence (AI)
Key Points
-
Alphabet is a leader in both AI and quantum computing.
-
Taiwan Semiconductor chips will be used regardless of the technology.
» Read more about: 3 Genius Ways to Invest in Quantum Computing and Artificial Intelligence (AI) »